Department of Pharmacy: Recent submissions

Now showing items 821-840 of 987

Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agents

Murugesan, Sankaranarayanan (Future Science Group, 2022-06)

To synthesize and screen phenanthridine and 1,2,3-triazole derivatives for antileishmanial activity. Methodology: Synthesized analogs were tested for antileishmanial activity against transgenic strain of Leishmania infantum ...
Targeting a conserved pocket (n-octyl-β-D–glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors

Murugesan, Sankaranarayanan (Taylor & Francis, 2020-12)

Dengue virus enters the cell by receptor-mediated endocytosis followed by a viral envelope (DENVE) protein-mediated membrane fusion. A small detergent molecule n-octyl-β-D–glucoside (βOG) occupies the hydrophobic pocket ...
In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat

Murugesan, Sankaranarayanan (Elsevier, 2022-08)

Obesity is an abnormal fat accumulation disorder in the metabolic syndrome constellation, and a risk factor for diabetes, cardiovascular disorders, non-alcoholic fatty liver disease (NAFLD), and cancer. Nuclear receptors ...
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19

Murugesan, Sankaranarayanan (MDPI, 2022)

SARS-CoV-2 is the cause of the COVID-19 pandemic which has claimed more than 6.5 million lives worldwide, devastating the economy and overwhelming healthcare systems globally. The development of new drug molecules and ...
Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein

Murugesan, Sankaranarayanan (Tabriz University of Medical Sciences, 2022)

Parkinson's disease (PD) is a chronic, devastating neurodegenerative disorder marked by the death of dopaminergic neurons in the midbrain's substantia nigra pars compacta (Snpc). In alpha-synuclein (α-Syn) self-aggregation, ...
Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection

Murugesan, Sankaranarayanan (MDPI, 2022-10)

The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given circa 7817 licenced compounds available from ...
CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19

Murugesan, Sankaranarayanan (MDPI, 2022-11)

Although various vaccines are now commercially available, they have not been able to stop the spread of COVID-19 infection completely. An excellent strategy to get safe, effective, and affordable COVID-19 treatments quickly ...
Design and study of novel chromone and thiochromone derivatives as PfLDH inhibitors — computational approach

Murugesan, Sankaranarayanan (Springer, 2022-06)

Malaria is one of the most neglected diseases in the South African countries, which leads to many deaths each year and the currently available drugs in the market are day-by-day acquiring resistance towards the plasmodium ...
Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-a]pyridine analogues

Murugesan, Sankaranarayanan (RSC, 2022)

Based on the molecular hybridization strategy, thirty-four imidazo[1,2-a]pyridine amides (IPAs) and imidazo[1,2-a]pyridine sulfonamides (IPSs) were designed and synthesized. The structures of the target compounds were ...
Molecular Docking and Dynamics Identifies Potential Repurposed Drug Candidates for COVID-19 Studies

Murugesan, Sankaranarayanan (2023-01)

The novel coronavirus disease 19 (COVID-19) has resulted in an estimated 20 million excess deaths and the recent resurgence of COVID-19 in China is predicted to result in up to 1 million deaths over the next few months. ...
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates

Murugesan, Sankaranarayanan (MDPI, 2023-04)

Due to the lack of specific vaccines, management of the trypanosomatid-caused neglected tropical diseases (sleeping sickness, Chagas disease and leishmaniasis) relies exclusively on pharmacological treatments. Current drugs ...
Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches

Murugesan, Sankaranarayanan (Taylor & Francis, 2023-04)

Sickle cell disease (SCD) is an autosomal recessive genetic disorder affecting millions of people worldwide. A reversible and selective DNMT1 inhibitor, GSK3482364, has been known to decrease the overall methylation activity ...
Discovery of Novel Coumarin-Schiff Base Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, Enzyme Inhibition, and Computational Studies

Murugesan, Sankaranarayanan (MDPI, 2023-07)

To discover anti-acetylcholinesterase agents for the treatment of Alzheimer’s disease (AD), a series of novel Schiff base-coumarin hybrids was rationally designed, synthesized successfully, and structurally characterized ...
Pharmacoinformatics-Based Approach for Uncovering the Quorum-Quenching Activity of Phytocompounds against the Oral Pathogen, Streptococcus mutans

Murugesan, Sankaranarayanan (MDPI, 2023-07)

Streptococcus mutans, a gram-positive oral pathogen, is the primary causative agent of dental caries. Biofilm formation, a critical characteristic of S. mutans, is regulated by quorum sensing (QS). This study aimed to ...
In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein

Murugesan, Sankaranarayanan; Deepa, P. R.; Garg, Mohit (Elsevier, 2023-07)

Novel nature of the viral pathogen SARS-CoV-2 and the absence of standard drugs for treatment, have been a major challenge to combat this deadly infection. Natural products offer safe and effective remedy, for which ...
Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds

Murugesan, Sankaranarayanan (Elsevier, 2023-09)

Leishmaniasis is a complex of neglected tropical diseases caused by various species of leishmanial parasites that primarily affect the world's poorest people. A limited number of standard medications are available for this ...
Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents—A Mini Review

Murugesan, Sankaranarayanan (MDPI, 2023)

The human immunodeficiency virus (HIV) is the primary cause of acquired immune deficiency syndrome (AIDS), one of the deadliest pandemic diseases. Various mechanisms and procedures have been pursued to synthesise several ...
2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies

Murugesan, Sankaranarayanan (ACS, 2023-11)

The aurora kinase is a key enzyme that is implicated in tumor growth. Research revealed that small molecules that target aurora kinase have beneficial effects as anticancer agents. In the present study, in order to identify ...
In Silico Exploration of Bisphosphonate Scaffolds as Potential Inhibitors of SARS-CoV-2 RdRp for COVID-19 and PASC

Murugesan, Sankaranarayanan (2023-11)

The novel coronavirus disease (COVID-19) pandemic has resulted in over 720 million confirmed cases and 7 million deaths worldwide, with insufficient treatment options. Innumerable efforts are being made around the world ...
Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids

Murugesan, Sankaranarayanan (Taylor & Francis, 2023-01)

The major enzyme responsible for the hydrolytic breakdown of the neurotransmitter acetylcholine (ACh) is acetylcholinesterase (AChE). Acetylcholinesterase inhibitors (AChEIs) are the most prescribed class of medications ...

Now showing items 821-840 of 987

Search DSpace

Advanced Search

Browse

All of DSpace
This Collection
- By Issue Date
- Authors
- Titles
- Subjects

Recently added

Department of Pharmacy: Recent submissions

Search DSpace

Browse

All of DSpace

This Collection

My Account